GEM

Indian Army Department of Military Affairs Medical Supplies Tender 2025: ISI/AAA compliant pharmaceuticals and injections in India

Posted

19 Oct 2025, 09:32 am

Deadline

10 Nov 2025, 10:00 am

EMD

₹17,800

Value

₹61,82,890

Location

JABALPUR , MADHYA PRADESH

Progress

Issue19 Oct 2025, 09:32 am
AwardPending
Explore all 4 tabs to view complete tender details

Quantity

167906

Category

INJ HUMAN INSULIN GLARGINE MONOC

Bid Type

Two Packet Bid

Categories 7

CHOCOLATE SUGARS AND SWEETENING PRODUCTS STRIP ANTIBIOTICS PEN CALCIUM SUPPLY METHYLCOBALAMINE TRANSITION METALS

Tender Overview

The Indian Army, Department of Military Affairs, invites bids for a broad range of medicinal injections and pharmaceuticals including insulin variants, antineoplastic agents, vitamins, antibiotics, and related IV/IM preparations. The estimated contract value is ₹6,182,890 with an EMD of ₹17,800. The scope encompasses 92 BOQ items with multiple product categories (antidiabetics, antineoplastics, antibiotics, vitamins, minerals, transfusion accessories). The buyer reserves a 25% quantity variation during contract; delivery timing ties to the original delivery window with adjustments per option clause. This tender targets suppliers capable of large-scale medical supply fulfillment for military medical facilities. Unique aspects include diverse product lines and a strict department-level procurement standard.

Keywords: tender in India, Indian Army procurement, medical injections tender 2025, Department of Military Affairs bids, pharmaceutical supply contract 2025.

Technical Specifications & Requirements

  • Product scope includes: INJ erythropoietin recombinant, insulin glargine and isophane, iron sucrose, folates and vitamins, antiemetic and chemotherapeutic agents, anti-infectives, adrenergic and cardiovascular meds, geographies unspecified.
  • Quantity details are not enumerated item-wise; BOQ comprises 92 items with N/A placeholders, suggesting a framework contract rather than fixed lots.
  • Estimated value: ₹6,182,890; EMD: ₹17,800.
  • Standards or technical specs are not explicitly listed; bidders should verify compliance with national pharmacopoeia and relevant IS/ISO certifications where applicable.
  • Delivery terms hinge on the option clause allowing up to 25% quantity variation and delivery extensions; ensure capacity to scale within consented rates.

Terms, Conditions & Eligibility

  • EMD: ₹17,800 (details not specified beyond amount).
  • Quantity variation: up to 25% more or less during contract; extension rules apply with a minimum delivery extension.
  • Delivery timeline: tied to original order date; extension calculated as (additional quantity/original quantity) × original delivery period, minimum 30 days.
  • Compliance: bidders must follow the Buyer Added Terms and ensure adherence to option clause; no tender ID or dates to be mentioned in responses.
  • Documents: GST, PAN, experience certificates, financials, and technical/commercial bid documents are likely required per standard government medical procurement practices.
  • Penalties/LD: not explicitly stated; ensure risk mitigation for delivery delays or non-conformance.

Key Specifications

    • Product categories include a broad range of injections and related pharmaceuticals: INJ erythropoietin recombinant, INJ insulin glargine, INJ insulin isophane NPH, INJ methylcobalamin, INJ leuprolide, INJ methotrexate, INJ vancomycin, ISOSORBIDE derivatives, L-carnitine injections, Ivermectin tablets/injections, isosorbide mononitrate, etc.
    • Estimated contract value: ₹6,182,890; EMD: ₹17,800
    • BOQ reports 92 items; many entries marked N/A, indicating framework/unspecified lot structure
    • No explicit standards provided in tender text; bidders should ensure compliance with national pharmacopoeia and GMP norms where applicable
    • Option clause allows up to 25% quantity variation during contract and possible extension of delivery period

Terms & Conditions

  • Key Term 1: EMD amount ₹17,800 to accompany bid

  • Key Term 2: Quantity variation up to 25% during contract

  • Key Term 3: Delivery period may extend based on option clause with minimum 30 days

Important Clauses

Payment Terms

Not explicitly stated; bidders should prepare for standard government payment terms (e.g., 30-45 days after delivery) and ensure compliant invoicing alignment with delivery receipts.

Delivery Schedule

Delivery commences per original delivery order; extended time calculated via (additional/original) × original delivery period; minimum 30 days, with possible extension during option exercise.

Penalties/Liquidated Damages

Not detailed in buyer terms; bidders should anticipate LDs for late delivery or non-conformance per applicable government procurement rules.

Bidder Eligibility

  • Experience in supplying hospital/pharmacy injections or pharmaceutical products to government or large institutions

  • Financial stability evidenced by audited statements

  • GST registration and PAN verified

  • Compliance with applicable medical regulatory standards for import/submission of pharmaceutical products

Bill of Quantities (BOQ) 92 Items

Item # Title Description Quantity Unit Consignee Delivery (Days)
1 INJ ERYTHROPOIETIN RECOMBINANT H INJ ERYTHROPOIETIN RECOMBINAN 20 nos dglpproc2023 30
2 INJ ERYTHROPOIETIN RECOMBINANT INJ ERYTHROPOIETIN RECOMBINANT 20 no dglpproc2023 30
3 INJ HUMAN INSULIN GLARGINE MONOC INJ HUMAN INSULIN GLARGINE MONO 2,800 pfs dglpproc2023 30
4 INJ HAEMACCEL CALCIUM CHLORIDE INJ HAEMACCEL CALCIUM CHLORID 30 bott dglpproc2023 30
5 INJ HUMAN MIXTARD 30 70 INJ HUMAN MIXTARD 30 70 294 vial dglpproc2023 30
6 INJ HUMAN MIXTARD 50 50 INJ HUMAN MIXTARD 50 50 90 vial dglpproc2023 30
7 INJ INSULIN ISOPHANE NPH 50 perc INJ INSULIN ISOPHANE NPH 50 per 180 vial dglpproc2023 30
8 INJ IRON SUCROSE INJ IRON SUCROSE 300 vial dglpproc2023 30
9 INJ LEUCOVORIN 50 MG 5 ML INJ LEUCOVORIN 50 MG 5 ML 12 vial dglpproc2023 30
10 INJ LEUPROLIDE 45 INJ LEUPROLIDE 45 6 no dglpproc2023 30
11 INJ LEVOCARNITINE 500 INJ LEVOCARNITINE 500 180 no dglpproc2023 30
12 INJ LUPRIDE 11.25 INJ LUPRIDE 11.25 6 no dglpproc2023 30
13 INJ METHOTREXATE 25 MG 2 ML INJ METHOTREXATE 25 MG 2 ML 6 vial dglpproc2023 30
14 INJ METHYL PREDNISOLONE 40 MG INJ METHYL PREDNISOLONE 40 MG 170 vial dglpproc2023 30
15 INJ METHYLCOBALAMIN 1500 MCG INJ METHYLCOBALAMIN 1500 MCG 1,200 no dglpproc2023 30
16 INJ METHYLCOBALAMINE MECOVIT 500 INJ METHYLCOBALAMINE MECOVIT 640 no dglpproc2023 30
17 INJ METHYLPREDNISOLE ACETATE 40 INJ METHYLPREDNISOLE ACETATE 40 30 vial dglpproc2023 30
18 INJ OLANZAPINE 405 MG INJ OLANZAPINE 405 MG 12 no dglpproc2023 30
19 INJ PALIPERIDONE PALMITATE 100 MG INJ PALIPERIDONE PALMITATE 100 MG 120 no dglpproc2023 30
20 INJ PHENYTOIN SODIUM INJ PHENYTOIN SODIUM 180 amp dglpproc2023 30
21 INJ TRIPTRELIN PAMORELIN 11.25 MG INJ TRIPTRELIN PAMORELIN 11.25 MG 6 no dglpproc2023 30
22 INJ VANCOMYCIN 1000 MG INJ VANCOMYCIN 1000 MG 12 no dglpproc2023 30
23 INJ VITAMIN D3 600000 IU ARACHITOL INJ VITAMIN D3 600000 IU ARACHITOL 78 amp dglpproc2023 30
24 INSULIN ACTRAPID 100 IU ML 3 ML PEN INSULIN ACTRAPID 100 IU ML 3 ML PEN 198 pen dglpproc2023 30
25 INSULIN DEGLUDEC 2.56 MG plus INSULIN DEGLUDEC 2.56 MG plus 240 pfs dglpproc2023 30
26 INSULIN DETEMIR 100 IU INJ INSULIN DETEMIR 100 IU INJ 6 pfs dglpproc2023 30
27 INSULIN ISOPHANE NPH 70 percent INSULIN ISOPHANE NPH 70 percent 660 vial dglpproc2023 30
28 INSULIN PREMIXED BIPHASIC HUMAN INSULIN PREMIXED BIPHASIC HUMAN 570 vial dglpproc2023 30
29 INTER DENTAL CLEANING ADD FLO INTER DENTAL CLEANING ADD FLO 600 nos dglpproc2023 30
30 INTRA VENOUS TRANSFUSION SET INTRA VENOUS TRANSFUSION SET 1,500 sachet dglpproc2023 30
31 IPRAVENT RESPULES IPRAVENT RESPULES 1,600 nos dglpproc2023 30
32 ISOSORBID 5 MG MONONTRATE 30 MG ISOSORBID 5 MG MONONTRATE 30 MG 1,800 nos dglpproc2023 30
33 ISOSORBID MONONITRATE 10 MG TAB ISOSORBID MONONITRATE 10 MG TAB 5,600 nos dglpproc2023 30
34 ISOSORBIDE DINITRATE 20 MG TAB ISOSORBIDE DINITRATE 20 MG TAB 1,200 nos dglpproc2023 30
35 ISOSORBIDE DINITRATE 5 MG TAB ISOSORBIDE DINITRATE 5 MG TAB 2,500 nos dglpproc2023 30
36 ISOSORBIDE MONONITRATE 30MG TAB ISOSORBIDE MONONITRATE 30MG TAB 1,300 nos dglpproc2023 30
37 ITOPRIDE 150 MG TAB ITOPRIDE 150 MG TAB 6,000 no dglpproc2023 30
38 ITRACONAZOLE 200 MG CAP ITRACONAZOLE 200 MG CAP 660 nos dglpproc2023 30
39 IVERMECTIN 12 MG TAB IVERMECTIN 12 MG TAB 1,000 nos dglpproc2023 30
40 KETOCONAZOLE 2 percent W V LOTIO KETOCONAZOLE 2 percent W V LOTIO 200 tube dglpproc2023 30
41 KETOCONAZOLE SHAMPO KETOCONAZOLE SHAMPO 400 bott dglpproc2023 30
42 KETODIASTIX STRIP KETODIASTIX STRIP 300 no dglpproc2023 30
43 KETORALAC 0.2 percent E D KETORALAC 0.2 percent E D 660 bott dglpproc2023 30
44 KETORALAC 0.5 percent E D KETORALAC 0.5 percent E D 60 bott dglpproc2023 30
45 L ARGININE SACHET 6.4 GM L ARGININE SACHET 6.4 GM 300 sachet dglpproc2023 30
46 L ORNITHINE L ASPARATE POWDER 5 L ORNITHINE L ASPARATE POWDER 5 60 sachet dglpproc2023 30
47 LABETALOL 100 MG TAB LABETALOL 100 MG TAB 1,500 nos dglpproc2023 30
48 LACOSAMIDE 100 mg TAB LACOSAMIDE 100 mg TAB 6,900 nos dglpproc2023 30
49 LACOSAMIDE 200 MG TAB LACOSAMIDE 200 MG TAB 1,800 nos dglpproc2023 30
50 LACOSAMIDE 50 mgTAB LACOSAMIDE 50 mgTAB 2,400 nos dglpproc2023 30
51 LACTITOL 10 GM plus ISPAGHULA 3.5 LACTITOL 10 GM plus ISPAGHULA 3.5 600 sachet dglpproc2023 30
52 LACTOBACILLUS 1 GM SACHET LACTOBACILLUS 1 GM SACHET 1,500 no dglpproc2023 30
53 LAMOTRIGINE 100 mg TAB LAMOTRIGINE 100 mg TAB 2,100 nos dglpproc2023 30
54 LANSOPRAZOLE 15 MG CAP LANSOPRAZOLE 15 MG CAP 3,100 no dglpproc2023 30
55 LANSOPRAZOLE 30 MG CAP LANSOPRAZOLE 30 MG CAP 1,800 no dglpproc2023 30
56 LEUPROLIDE ACETATE 11.25 MG INJ LEUPROLIDE ACETATE 11.25 MG INJ 12 no dglpproc2023 30
57 LEVETIRACETAM 250 MG TAB LEVETIRACETAM 250 MG TAB 14,900 nos dglpproc2023 30
58 LEVETIRACETAM 750 MG TAB LEVETIRACETAM 750 MG TAB 400 nos dglpproc2023 30
59 LEVETIRACETAM SR 500 mg TAB LEVETIRACETAM SR 500 mg TAB 400 nos dglpproc2023 30
60 LEVOCARNITINE 1 GM INJECTION LEVOCARNITINE 1 GM INJECTION 280 no dglpproc2023 30
61 LEVOCARNITINE 500 MG TAB LEVOCARNITINE 500 MG TAB 6,600 nos dglpproc2023 30
62 LEVO CARNITINE 500MG METHYCOBA LEVO CARNITINE 500MG METHYCOBA 7,000 no dglpproc2023 30
63 LEVODOPA 100 mg plus CARBIDOPA LEVODOPA 100 mg plus CARBIDOPA 1,900 nos dglpproc2023 30
64 LEVODOPA 125 MG TAB LEVODOPA 125 MG TAB 120 nos dglpproc2023 30
65 LEVODOPA 200 mg plus CARBIDOPA LEVODOPA 200 mg plus CARBIDOPA 240 nos dglpproc2023 30
66 LEVOSALBUTAMOL 100 MCG plus LEVOSALBUTAMOL 100 MCG plus 2,280 no dglpproc2023 30
67 LEVOSALBUTAMOL 100MCG plus IPRAT LEVOSALBUTAMOL 100MCG plus IPRAT 3,480 no dglpproc2023 30
68 LEVOSALBUTAMOL 2 MG TAB LEVOSALBUTAMOL 2 MG TAB 1,200 nos dglpproc2023 30
69 LEVOSULPIRIDE 75 mg plus ESOMEP LEVOSULPIRIDE 75 mg plus ESOMEP 3,000 nos dglpproc2023 30
70 LEVOSULPRIDE 50 mg TAB LEVOSULPRIDE 50 mg TAB 1,860 nos dglpproc2023 30
71 LIDOCAINE 4 percent W W plus ME LIDOCAINE 4 percent W W plus ME 12 nos dglpproc2023 30
72 LIGNOCAIN plus GABAPENTIN OINT LIGNOCAIN plus GABAPENTIN OINT 24 tube dglpproc2023 30
73 LINAGLIPTIN 2.5 MG TAB LINAGLIPTIN 2.5 MG TAB 1,600 nos dglpproc2023 30
74 LINAGLIPTIN 5 MG plus EMPAGLIFLOZ LINAGLIPTIN 5 MG plus EMPAGLIFLOZ 300 no dglpproc2023 30
75 LINAGLIPTIN 5 Nos plus METFORMIN LINAGLIPTIN 5 Nos plus METFORMIN 6,300 nos dglpproc2023 30
76 LIQ PARAFFIN 100 ML BOTT LIQ PARAFFIN 100 ML BOTT 120 ml dglpproc2023 30
77 LISINOPRIL 2.5 MG TAB LISINOPRIL 2.5 MG TAB 180 no dglpproc2023 30
78 LISINOPRIL 5 MG TAB LISINOPRIL 5 MG TAB 120 nos dglpproc2023 30
79 LITHIUM CARBONATE SR 400 mg TAB LITHIUM CARBONATE SR 400 mg TAB 1,800 nos dglpproc2023 30
80 LORATADINE 10 MG TAB LORATADINE 10 MG TAB 600 nos dglpproc2023 30
81 LORAZEPAM 2 MG TAB LORAZEPAM 2 MG TAB 5,400 nos dglpproc2023 30
82 L ORNITHINE L ASPARTATE TAB H L ORNITHINE L ASPARTATE TAB H 1,200 no dglpproc2023 30
83 LORNOXICAM 8 MG plus THICOLCHI LORNOXICAM 8 MG plus THICOLCHI 3,000 no dglpproc2023 30
84 LOSARTAN 50 MG plus HYDROCH LOSARTAN 50 MG plus HYDROCH 31,200 nos dglpproc2023 30
85 LURASIDONE 40 mg TAB LURASIDONE 40 mg 300 nos dglpproc2023 30
86 METHOTREXATE 15 MG TAB METHOTREXATE 15 MG 1,500 no dglpproc2023 30
87 PAROXETIN 25 mg TAB PAROXETIN 25 mg TAB 3,600 nos dglpproc2023 30
88 CLOZAPINE 50 mg TAB CLOZAPINE 50 mg TAB 5,100 nos dglpproc2023 30
89 RANOLAZINE 500 mg TAB RANOLAZINE 500 mg TAB 5,700 nos dglpproc2023 30
90 CABERGOLINE 0.25 MG TAB CABERGOLINE 0.25 MG TAB 480 nos dglpproc2023 30
91 LEUPROLIDE ACETATE 3.75 MG INJE LEUPROLIDE ACETATE 3.75 MG INJE 12 no dglpproc2023 30
92 LORLATINIB 25 mg TAB LORLATINIB 25 mg TAB 180 nos dglpproc2023 30

AI-Powered Bidder Prediction

Companies most likely to bid

Unlock Bidder Insights

AI predictions on likely bidders

Required Documents

1

GST registration certificate

2

Permanent Account Number (PAN) card

3

Experience certificates for similar medical supply contracts

4

Audited financial statements or financial solvency certificate

5

EMD payment proof (bank guarantee or DD as permitted)

6

Technical bid and product compliance certificates

7

OEM authorizations for pharmaceutical products (if applicable)

Frequently Asked Questions

How to bid in the Indian Army medical injections tender 2025?

Bidders should prepare GST registration, PAN, financials, experience certificates, and an EMD of ₹17,800. Ensure OEM authorizations where required and compliance with pharmacopoeial standards. Submit a technical bid detailing product compliance and a commercial bid aligned with the 25% quantity variation option clause.

What documents are required for the Indian Army medical tender 2025?

Required documents include GST certificate, PAN, audited financials, experience certificates for hospital injections, EMD proof, technical compliance certificates, and OEM authorizations for products. Ensure submission of all 92 BOQ items as applicable and alignment with standard government formats.

What are the delivery terms for the Indian Army medical supplies tender 2025?

Delivery follows the original delivery order; additional time is calculated as (additional quantity/original quantity) × original delivery period, with a minimum of 30 days. The buyer may extend delivery time during option exercise, affecting total schedule and penalties if any.

What is the EMD amount for the Indian Army medical procurement 2025?

The EMD for this tender is ₹17,800. It should be submitted via the approved bank instrument or online method per the tender terms, linked to the technical bid, ensuring bid validity through the contract award window.

Which product categories are covered by this military medical tender 2025?

The scope includes injections such as erythropoietin recombinant, various insulin analogs, vitamins, methotrexate, iron sucrose, vancomycin, lactobacilli preparations, and other reported injections and oral formulations; BOQ lists 92 items with some entries marked N/A indicating framework coverage.

What standards or compliance are required for this Indian Army procurement?

No explicit standards are listed in the tender text; bidders should ensure ISI/ISO GMP-compliant manufacturing or supply processes where applicable and align with national pharmacopoeia requirements for injectable medicines and critical drugs.

When is the bid submission deadline for the 2025 Indian Army tender?

Dates are not provided in the available data. Bidders should monitor the official portal for bid submission deadlines and ensure readiness with complete GST, PAN, EMD, and technical/commercial bids prior to the publish date.

What is the estimated value and quantity scope for the Indian Army medical tender 2025?

Estimated contract value is ₹6,182,890 with an EMD of ₹17,800. The BOQ contains 92 items; several entries show N/A, indicating a framework or large-scale supply contract rather than fixed-quantity commitments.